In this episode, we sit down with scientist and entrepreneur Daniel J. Mandell, Ph.D. Daniel is the Chief Executive Officer, Co-Founder, and Director of GRO Biosciences, a genome engineering, computational biology, and therapeutic development company that is expanding the amino acid alphabet to make better medicines.
Originally trained in AI and machine learning at Stanford University, Daniel went on to become the leading expert in synthetic biology, protein engineering, artificial intelligence, and biological and medical informatics. Now, he is at the forefront of a new technology that is breaking barriers in order to reach the unmet clinical needs of patients from all walks of life…
In this conversation, Daniel discusses:
- The building blocks of amino acids.
- What “nonstandard amino acids” are, and what GRO Biosciences is doing with them.
- The key properties that GRO Biosciences is building into proteins, and how this can improve the immune system.
- How antigens influence the immune system’s functionality.
